CD19 and lymphoma: In another recent study by Stein-Thoeringer et al., an association between exposure to ATBs prior to CD19 CAR-T cell infusion and increased incidences of cancer relapse/disease progression and worse overall survival (OS) in lymphoma patients was also observed (24).